www.ogscience.org 177
Letter to the Editor
Obstet Gynecol Sci 2018;61(2):177-178
https://doi.org/10.5468/ogs.2018.61.2.177
pISSN 2287-8572 · eISSN 2287-8580
We read with interest the article by Hwang et al. [1] which re-
ported a case of delayed intestinal perforation, uterine perfo-
ration with recto-uterine fistula and vertebral osteomyelitis 29
days after high-intensity focused ultrasound (HIFU) treatment
for uterine leiomyoma. This article reminds physicians that
while HIFU is increasingly being considered an effective and
safe option for treatment of uterine leiomyomas [2-4], often
for women who wish uterine preservation, potentially serious
complications can occur.
Recently, we have also encountered a woman with adeno-
myosis who presented with intestinal perforation 8 days after
HIFU [5]. Consistent with the findings from Hwang et al.'s
case [1] together with 2 other cases reported by Chen et al.
[6] (presented at 10 and 20 days following HIFU), this de -
layed presentation appears to be quite indicative of intestinal
damage following HIFU. We speculate that tissue ablation
at a temperature of only 56°C–90°C from HIFU results in a
subtle and delayed intestinal damage, which may not even be
obvious on imaging studies [5]. We stress the importance of
physician's alertness of this delayed presentation for early rec-
ognition and timely management of intestinal injury following
HIFU treatment.
Furthermore, prevention of such occurrence is equally
important. This patient reported by Hwang et al. [1] had
multiple previous abdominal surgeries including myomec -
tomy, appendectomy and caesarean section; clearly at risk of
extensive pelvic adhesions. In many centers, including ours,
patients with known or suspected extensive pelvic adhesions,
or bowel adherent to the uterus or abdominal wall, such as a
history of major abdominal or pelvic surgery, pelvic inflamma-
tory disease, or pelvic endometriosis, are generally considered
contraindications for HIFU treatment [2-4]. This case illustrates
the importance of proper patient selection when considering
HIFU for uterine leiomyomas or adenomyosis, as a simple and
effective means to avoid complications arising from this treat-
ment modality.
Conflict of Interest
No potential conflict of interest relevant to this article was re-
ported.
References
1. Hwang DW, Song HS, Kim HS, Chun KC, Koh JW,
Kim YA. Delayed intestinal perforation and vertebral
osteomyelitis after high-intensity focused ultrasound
treatment for uterine leiomyoma. Obstet Gynecol Sci
Comment on: Delayed intestinal perforation and vertebral
osteomyelitis after high-intensity focused ultrasound
treatment for uterine leiomyoma
Jennifer K.Y . Ko, Vincent Y .T. Cheung
Department of Obstetrics and Gynaecology, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China
Received: 2017.11.27. Revised: 2017.12.05. Accepted: 2017.12.05.
Corresponding author: Jennifer K.Y . Ko
Department of Obstetrics and Gynaecology, Queen Mary Hospital,
The University of Hong Kong, 6/F , Professorial Block, 102 Pok Fu
Lam Road, Hong Kong, China
E-mail:
[email protected]
https://orcid.org/0000-0003-0475-0645
Articles published in Obstet Gynecol Sci are open-access, distributed under the terms of
the Creative Commons Attribution Non-Commercial License (http://creativecommons.
org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution,
and reproduction in any medium, provided the original work is properly cited.
Copyright © 2018 Korean Society of Obstetrics and Gynecology
www.ogscience.org178
Vol. 61, No. 2, 2018
2017;60:490-3.
2. Cheung VY. Sonographically guided high-intensity
focused ultrasound for the management of uterine fi -
broids. J Ultrasound Med 2013;32:1353-8.
3. Cheung VY. High-intensity focused ultrasound therapy.
Best Pract Res Clin Obstet Gynaecol 2018;46:74-83.
4. Zhang L, Rao F, Setzen R. High intensity focused ultra -
sound for the treatment of adenomyosis: selection cri -
teria, efficacy, safety and fertility. Acta Obstet Gynecol
Scand 2017;96:707-14.
5. Ko JK, Seto MT, Cheung VY. Thermal bowel injury after
ultrasound-guided high-intensity focused ultrasound for
uterine adenomyosis. Ultrasound Obstet Gynecol 2017
Nov 20 [Epub]. http://dx.doi.org/10.1002/uog.18965.
6. Chen J, Chen W, Zhang L, Li K, Peng S, He M, et al.
Safety of ultrasound-guided ultrasound ablation for
uterine fibroids and adenomyosis: a review of 9988
cases. Ultrason Sonochem 2015;27:671-6.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.